To assess the possible interactions among candidate anti-influenza age
nts, dual combinations of rimantadine, ribavirin, 2'-deoxy-2'-fluorogu
anosine (S-FDG) and 4-guanidino-Neu5Ac2en (GG167) were tested against
clinical isolates of influenza A H3N2 and H1N1 subtype viruses in MDCK
cells by ELISA. Each of the dual combinations showed additive effects
, except for the combination of 2-FDG and ribavirin which was synergis
tic against the influenza A (H1N1) virus. However, this combination al
so enhanced cytotoxicity, In this assay influenza agents with differin
g mechanisms of antiviral interaction interacted in an additive fashio
n with respect to inhibition of viral replication,